Parsons Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Sell |
11,800
-1,967
| -14% | -$302K | 0.08% | 204 |
|
|
2025
Q4 | $1.9M | Hold |
13,767
| – | – | 0.1% | 177 |
|
|
2025
Q3 | $1.77M | Sell |
13,767
-66
| -0.5% | -$8.05K | 0.1% | 183 |
|
|
2025
Q2 | $1.67M | Sell |
13,833
-27
| -0.2% | -$3.04K | 0.1% | 181 |
|
|
2025
Q1 | $1.55M | Buy |
13,860
+122
| +0.9% | +$13K | 0.08% | 195 |
|
|
2024
Q4 | $1.34M | Sell |
13,738
-1,078
| -7% | -$115K | 0.07% | 210 |
|
|
2024
Q3 | $1.7M | Sell |
14,816
-185
| -1% | -$21K | 0.11% | 173 |
|
|
2024
Q2 | $1.6M | Sell |
15,001
-1,094
| -7% | -$110K | 0.11% | 173 |
|
|
2024
Q1 | $1.56M | Sell |
16,095
-1,014
| -6% | -$104K | 0.11% | 177 |
|
|
2023
Q4 | $1.73M | Sell |
17,109
-915
| -5% | -$88.3K | 0.12% | 167 |
|
|
2023
Q3 | $1.84M | Sell |
18,024
-45
| -0.2% | -$4.57K | 0.15% | 141 |
|
|
2023
Q2 | $1.82M | Buy |
18,069
+189
| +1% | +$18.9K | 0.14% | 149 |
|
|
2023
Q1 | $1.64M | Sell |
17,880
-4,276
| -19% | -$373K | 0.13% | 157 |
|
|
2022
Q4 | $2.01M | Sell |
22,156
-890
| -4% | -$75K | 0.17% | 126 |
|
|
2022
Q3 | $1.75M | Sell |
23,046
-3,169
| -12% | -$263K | 0.16% | 133 |
|
|
2022
Q2 | $2.22M | Sell |
26,215
-1,063
| -4% | -$93.3K | 0.2% | 111 |
|
|
2022
Q1 | $2.39M | Sell |
27,278
-313
| -1% | -$27.1K | 0.18% | 121 |
|
|
2021
Q4 | $2.41M | Buy |
27,591
+1,353
| +5% | +$112K | 0.17% | 123 |
|
|
2021
Q3 | $2.15M | Sell |
26,238
-3,493
| -12% | -$314K | 0.17% | 129 |
|
|
2021
Q2 | $2.71M | Buy |
29,731
+2,515
| +9% | +$224K | 0.21% | 106 |
|
|
2021
Q1 | $2.33M | Sell |
27,216
-2,405
| -8% | -$216K | 0.19% | 117 |
|
|
2020
Q4 | $2.8M | Buy |
29,621
+2,278
| +8% | +$199K | 0.24% | 93 |
|
|
2020
Q3 | $2.38M | Sell |
27,343
-2,081
| -7% | -$180K | 0.23% | 91 |
|
|
2020
Q2 | $2.57M | Buy |
29,424
+2,253
| +8% | +$194K | 0.27% | 82 |
|
|
2020
Q1 | $2.24M | Sell |
27,171
-1,224
| -4% | -$109K | 0.29% | 81 |
|
|
2019
Q4 | $2.69M | Sell |
28,395
-234
| -0.8% | -$21K | 0.27% | 89 |
|
|
2019
Q3 | $2.49M | Buy |
28,629
+393
| +1% | +$35.3K | 0.27% | 92 |
|
|
2019
Q2 | $2.58M | Sell |
28,236
-3,263
| -10% | -$276K | 0.28% | 87 |
|
|
2019
Q1 | $2.71M | Buy |
31,499
+403
| +1% | +$32.4K | 0.3% | 82 |
|
|
2018
Q4 | $2.39M | Buy |
31,096
+243
| +0.8% | +$18.9K | 0.29% | 82 |
|
|
2018
Q3 | $2.38M | Buy |
30,853
+217
| +0.7% | +$16K | 0.25% | 100 |
|
|
2018
Q2 | $2.07M | Buy |
30,636
+429
| +1% | +$29.6K | 0.23% | 103 |
|
|
2018
Q1 | $2.19M | Sell |
30,207
-1,399
| -4% | -$106K | 0.25% | 102 |
|
|
2017
Q4 | $2.38M | Buy |
31,606
+14
| +0% | +$1.06K | 0.26% | 99 |
|
|
2017
Q3 | $2.43M | Buy |
31,592
+190
| +0.6% | +$14.3K | 0.29% | 93 |
|
|
2017
Q2 | $2.35M | Buy |
31,402
+1,267
| +4% | +$89.8K | 0.29% | 92 |
|
|
2017
Q1 | $2.01M | Buy |
30,135
+820
| +3% | +$54.6K | 0.25% | 104 |
|
|
2016
Q4 | $1.91M | Buy |
29,315
+15,183
| +107% | +$985K | 0.25% | 101 |
|
|
2016
Q3 | $1M | Buy |
14,132
+768
| +6% | +$56K | 0.13% | 160 |
|
|
2016
Q2 | $988K | Sell |
13,364
-1,231
| -8% | -$85K | 0.13% | 163 |
|
|
2016
Q1 | $947K | Sell |
14,595
-280
| -2% | -$19K | 0.13% | 168 |
|
|
2015
Q4 | $1.15M | Sell |
14,875
-313
| -2% | -$24.9K | 0.16% | 147 |
|
|
2015
Q3 | $1.25M | Hold |
15,188
| – | – | 0.18% | 141 |
|
|
2015
Q2 | $1.34M | Sell |
15,188
-390
| -3% | -$35.8K | 0.18% | 144 |
|
|
2015
Q1 | $1.38M | Buy |
15,578
+1,439
| +10% | +$128K | 0.19% | 128 |
|
|
2014
Q4 | $1.17M | Buy |
14,139
+2,177
| +18% | +$180K | 0.16% | 145 |
|
|
2014
Q3 | $1.01M | Sell |
11,962
-45
| -0.4% | -$3.64K | 0.14% | 157 |
|
|
2014
Q2 | $975K | Sell |
12,007
-92
| -0.8% | -$7.24K | 0.13% | 161 |
|
|
2014
Q1 | $922K | Sell |
12,099
-371
| -3% | -$27K | 0.13% | 163 |
|
|
2013
Q4 | $899K | Buy |
12,470
+37
| +0.3% | +$2.57K | 0.13% | 161 |
|
|
2013
Q3 | $855K | Buy |
12,433
+136
| +1% | +$9K | 0.14% | 164 |
|
|
2013
Q2 | $779K | Buy |
+12,297
| New | +$800K | 0.13% | 163 |
|
Other funds holding NVS
Parsons Capital Management's NVS Position: Q1 2026 in Review
Parsons Capital Management reduced its Novartis (NVS) stake by 14% in Q1 2026, selling an estimated $302K and leaving 11,800 shares worth $1.8M. The position accounts for 0.08% of the portfolio, ranked #204.
Parsons Capital Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.8M in Q4 2020. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Parsons Capital Management held 11,800 shares of Novartis worth $1.8M as of Q1 2026.
- Parsons Capital Management sold 1,967 Novartis shares in Q1 2026, an estimated $302K.
- Novartis made up 0.08% of Parsons Capital Management's portfolio in Q1 2026, its #204 holding.
- Parsons Capital Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Parsons Capital Management's Novartis position peaked at $2.8M in Q4 2020.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.